Clinical Trials Integral to Providing More Treatment Options for Platinum-Resistant Ovarian Cancer (PROC)

Campaign: Alkermes Medicines & Focus: Cancer
Illustration of a medical professional talking to a patient who is sat on a chair

Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis due to the limited treatment options. Watch this video to learn more about PROC and why clinical trials are critical for researching potential options.